![Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data | International Journal of Obesity Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data | International Journal of Obesity](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41366-020-00733-x/MediaObjects/41366_2020_733_Fig1_HTML.png)
Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data | International Journal of Obesity
Trials4us - *PAID CLINICAL TRIAL FOR HEALTHY SMOKERS.* We are carrying out a clinical trial with next-generation nicotine products that are being developed as an alternative approach to conventional cigarettes. This study
![Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial - The Lancet Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/53144d04-ab2f-4bb1-a863-2cecf0e2b2d9/gr1_lrg.gif)
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial - The Lancet
Just Another Lab Rat! - PRA Health Sciences Paid Clinical Trial on Healthy, Non-Smoking Adults, Ages 18-55 in Lenexa, KS. Stipend: $2100 http://www.jalr.org/full/ks_pra_health_sciences.html #Healthy #Volunteers # Studies #trials #medical #research ...
![Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke - Value in Health Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke - Value in Health](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/54ffeebe-5364-450a-b111-5dc9db523203/gr1.jpg)
Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke - Value in Health
![Smoking Cessation (Teens Ages 12 through 16) - Multiple Locations in the U.S. (Clinical Trial # 21893) Smoking Cessation (Teens Ages 12 through 16) - Multiple Locations in the U.S. (Clinical Trial # 21893)](https://www.clinicalconnection.com/StudyFlyer/Study21893Flyer.jpg)